Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms

SARS-CoV causes an acute infection making targeted passive immunotherapy an attractive treatment strategy. We previously generated human mAbs specific to the S1 region of SARS-CoV S protein. These mAbs bind epitopes within the receptor binding domain (RBD) or upstream of the RBD. We show that mAbs r...

Descripción completa

Detalles Bibliográficos
Autores principales: Coughlin, Melissa M., Babcook, John, Prabhakar, Bellur S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111986/
https://www.ncbi.nlm.nih.gov/pubmed/19748648
http://dx.doi.org/10.1016/j.virol.2009.07.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111986/
https://www.ncbi.nlm.nih.gov/pubmed/19748648
http://dx.doi.org/10.1016/j.virol.2009.07.028

Ejemplares similares